Looking for volunteers
Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)
NCT06939023 · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Updated 4 Sept 2025
- What is being tested
- Laparoscopic minimally invasive left-sided pancreatecomy; Robot-assisted minimally invasive left-sided pancreatecomy
- For
- Pancreatectomy; Distal Pancreatectomy (DP); Pancreatic Neoplasms; Pancreatic Adenoma; Pancreatic Cyst; Pancreatic Cystadenoma; Surgery; Minimally Invasive Surgical Technique; Minimally Invasive Distal Pancreatectomy; Minimally Invasive Surgery
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 256 people. The full rules are on the registry page.
- Where
- Netherlands
- When
- Starts or started 1 June 2025, ends 1 June 2028. Registered 22 April 2025.
- Results
- None posted yet.
In the researchers' words
The DIPLOMA-3 trial is an international, multicenter, patient-blinded randomized controlled trial comparing laparoscopic and robot-assisted left-sided pancreatectomy. Patients with an indication for elective left-sided pancreatecomy for benign or premalignant lesions in the body or tail of the pancreas and considered eligible will be randomized between laparoscopic and robot-assisted resection.
Sites
- Amsterdam UMCAmsterdam, Netherlands